OrbiMed

Top Portfolio
Top Buys
Top Sells
New Buys
Exits
Xtant Medical Holdings, Inc.
XTNT
$85.54M56.1373.11M0%+$00.66
Verona Pharma plc
VRNA
$54.67M33.533.4M-10.05%-$6.11M0.42
Singular Genomics Systems, Inc.
OMIC
$278.03M21.89540,6970%+$02.15
Prelude Therapeutics Incorporated
PRLD
$51.71M19.8610.91M0%+$00.4
Enliven Therapeutics, Inc.
ELVN
$158.28M19.139M0%+$01.22
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.